Case reports of the use of immunoadsorption or plasma exchange in high-risk pregnancies of women with antiphospholipid syndrome

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 2, 2009, Pages 157-160

  Bortolati, Maria ^a,b   Marson, Piero ^d   Chiarelli, Silvia ^c   Tison, Tiziana ^d   Facchinetti, Myriam ^b   Gervasi, Maria Teresa ^a   De Silvestro, Giustina ^d   Ruffatti, Amelia ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b Department of Clinical and Experimental Medicine ^*  (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Blood Transfusion Unit   (Italy)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Immunoadsorption; Plasma exchange; Pregnancy

Indexed keywords

ANTITHROMBIN III; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LUPUS ANTICOAGULANT; NADROPARIN; PHENOBARBITAL; PHOSPHOLIPID ANTIBODY; WARFARIN;

ADULT; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH WEIGHT; CASE REPORT; CEREBROVASCULAR ACCIDENT; CESAREAN SECTION; COMPARATIVE STUDY; DEEP VEIN THROMBOSIS; DISEASE CONTROL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPSY; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; IMMUNOADSORPTION; INTRAUTERINE GROWTH RETARDATION; OLIGOHYDRAMNIOS; PLASMAPHERESIS; PREGNANCY COMPLICATION; PRIMIGRAVIDA; PRIORITY JOURNAL; THROMBOSIS; TREATMENT RESPONSE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; IMMUNOSORBENT TECHNIQUES; PLASMA EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK;

EID: 63349110639     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00671.x     Document Type: Article

References (12)

1. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996 174 : 1584 9.
2. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997 314 : 253 7.
3. Stone S, Hunt BJ, Seed PT, Parmar K, Khamashta MA, Poston L. Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy. Am J Obstet Gynecol 2003 188 : 454 60.
4. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 4 : 295 306.
5. Ruffatti A, Tonello M, Del Ross T et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 2006 96 : 337 41.
6. Ruffatti A, Marson P, Pengo V et al. Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature. Autoimmun Rev 2007 6 : 196 202.
7. Branch DW, Peaceman AM, Druzin M et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 2000 182 : 122 7.
8. Erkan D, Lockshin MD. New treatments for antiphospholipid syndrome. Rheum Dis Clin North Am 2006 32 : 129 48.
9. Kobayashi S, Tamura N, Tsuda H, Mokuno C, Hashimoto H, Hirose S. Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy. Ann Rheum Dis 1992 51 : 399 401.
10. D'Ippolito S, Di Simone N, Di Nicuolo F, Castellani R, Caruso A. Antiphospholipid antibodies: effects on trophoblast and endothelial cells. Am J Reprod Immunol 2007 58 : 150 8.
11. Salmon JE, Girardi G. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J Reprod Immunol 2008 77 : 51 6.
12. Bosch T. Therapeutic apheresis - state of the art in the year 2005. Ther Apher Dial 2005 9 : 459 68.